Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,531.00    1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread: 1.00 (0.065%)
Market Cap: £3.22b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

UPDATE 1-Blues health insurers put up $55 million to take on generic drug makers
23 Jan 2020

UPDATE 1-Blues health insurers put up $55 million to take on generic drug makers

(Adds detail on new venture)By Caroline HumerNEW YORK, Jan 23 (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a ve...

UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance
13 Jan 2020

UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance

UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance

Hikma inks exclusive agreement with Chiesi Farmaceutici
13 Jan 2020

Hikma inks exclusive agreement with Chiesi Farmaceutici

(Sharecast News) - British pharmaceutical company Hikma has inked an exclusive licensing and distribution agreement with Chiesi Farmaceutici, a resear...

Hikma Pharmaceuticals Signs Distribution Deal In Egypt With Chiesi
13 Jan 2020

Hikma Pharmaceuticals Signs Distribution Deal In Egypt With Chiesi

Hikma Pharmaceuticals Signs Distribution Deal In Egypt With Chiesi

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.

Hikma Teams With Arestat To Co-Develop Injectable Medicine In US
9 Jan 2020

Hikma Teams With Arestat To Co-Develop Injectable Medicine In US

Hikma Teams With Arestat To Co-Develop Injectable Medicine In US

Hikma, Arecor to co-develop injectable medicine in US
9 Jan 2020

Hikma, Arecor to co-develop injectable medicine in US

(Sharecast News) - Hikma Pharmaceuticals on Thursday said it had signed a deal with Arecor to co-develop a ready-to-use injectable medicine in the US.

LONDON MARKET CLOSE: US-Iran Tensions, Stronger Pound Hinder FTSE 100
6 Jan 2020

LONDON MARKET CLOSE: US-Iran Tensions, Stronger Pound Hinder FTSE 100

LONDON MARKET CLOSE: US-Iran Tensions, Stronger Pound Hinder FTSE 100